The classic operational principles of hypodermic needles have been well‑established around the linear process of "penetration, delivery and withdrawal". However, driven by the explosive growth of biotechnology, microelectronics, advanced materials and digital health, injection needles stand at a critical point of paradigm shift. Their role will evolve from passive, single‑function "execution tools" to proactive, multi‑functional "intelligent interfaces". The operational theories of future injection needles will deeply integrate sensing, feedback, regulation and information interaction capabilities, ushering in a new era of precision medicine.

I. Integrated Sensing and Real‑Time Monitoring: Endowing Needles with "Perception" Capabilities

Conventional needles are "blind", with penetration depth, position and tissue environment entirely dependent on operator experience. Next‑generation smart needles will integrate multiple miniature sensors.

Tissue Identification and Puncture Navigation

Impedance spectroscopy sensing: Different tissues (epidermis, dermis, subcutaneous fat, muscle, blood vessels) feature distinct electrical impedance properties. Micro‑electrodes integrated at the needle tip enable real‑time identification of tissue layers by measuring impedance changes. For instance, during subcutaneous insulin injection, the system can emit audio alerts to ensure the tip stays within fat tissue rather than muscle, avoiding hypoglycemia risks caused by rapid drug absorption.

Optical Coherence Tomography (OCT): Micrometre‑scale optical fibres embedded inside the needle lumen enable real‑time OCT imaging ahead of the tip. This delivers immense value in interventional therapies: when puncturing masses or performing nerve blocks, it directly visualises the micro‑structure of target tissues, avoiding blood vessels and nerves for visual‑guided precise puncture.

In‑situ Monitoring of Physiological Parameters

Minimally invasive blood glucose / biomarker monitoring: Needle surfaces can be functionally modified with specific enzymes or antibodies. Upon penetration into subcutaneous interstitial fluid, real‑time detection of biomarkers such as glucose, lactic acid and inflammatory factors is achieved. This provides a revolutionary tool for diabetes management (realising integrated "injection‑monitoring") or intensive care.

Pressure sensing: Miniature pressure sensors embedded in the needle hub or cannula monitor injection resistance. Abnormally high resistance may indicate needle blockage, tip contact with dense tissue or abnormal drug properties, triggering automatic system alerts or adjusted injection rates.

II. Miniaturised Platforms for Controlled Release and Targeted Drug Delivery

Beyond serving merely as delivery channels, future needles can function as miniature "lab‑on‑chip" devices.

Multi‑Lumen and Programmable Release NeedlesNeedle cannulas can be designed with parallel lumens loaded with different drugs or catalysts. Once positioned, agents are released sequentially or mixed according to pre‑set programmes to achieve sequential or trigger‑activated therapy - for example, injecting a local anaesthetic followed by the primary drug after a time delay.

Dissolvable Microneedles for Painless Transdermal Drug DeliveryPartially realised today, microneedle arrays hundreds of micrometres long, fabricated from sugars, polymers and other materials, are applied to the skin. They painlessly pierce the stratum corneum, rapidly dissolve subcutaneously, and release payloads such as vaccines, insulin and antibodies. Their operating principle shifts from "penetration‑withdrawal" to "penetration‑absorption", completely eliminating sharps waste and pain. They are particularly suitable for home‑based self‑administration and mass vaccination programmes.

Electric‑Field / Ultrasound‑Assisted DeliveryMicro‑electrodes integrated at the needle tip deliver weak electrical pulses (iontophoresis / electroporation) during injection, temporarily increasing cell membrane permeability and significantly boosting intracellular delivery efficiency of large‑molecule drugs such as DNA and monoclonal antibodies. Alternatively, miniature ultrasonic transducers can be embedded to promote drug diffusion in tissues via acoustic cavitation effects.

III. Closed‑Loop Feedback and Adaptive Injection Systems

Combining sensing and actuation, smart needles serve as terminal actuators for closed‑loop drug delivery systems.

Resistance‑Adaptive InjectionAs mentioned above, by monitoring injection pressure, the system dynamically adjusts infusion pump speed to deliver drugs at the optimal rate within tissue tolerance limits. This is especially applicable for large‑volume subcutaneous injection of high‑viscosity biologics such as monoclonal antibodies, preventing pain and nodule formation.

Feedback‑Driven Injection Based on Physiological SignalsEnvision an insulin injection needle integrated with blood glucose monitoring. After penetration, it rapidly measures interstitial fluid glucose levels, calculates the required insulin dosage via algorithms, and triggers precise delivery by a micro‑pump. The entire process completes automatically within tens of seconds, realising a true closed loop of "perception‑decision‑execution".

IV. Wireless Connectivity and Digitalised Management

Smart needles will become critical end‑point nodes for the Internet of Things in healthcare.

Automatic Recording of Injection DataMicro‑chips and wireless modules (e.g., NFC, Bluetooth) are integrated into needle hubs. Dosage, timing and estimated injection site (manually selected or automatically sensed via needle ID linked to mobile applications) are automatically recorded and synchronised to smartphone apps or cloud platforms. This is vital for conditions requiring strict injection logging such as diabetes and growth hormone therapy, resolving patient memory bias and record‑keeping burdens.

Adherence Monitoring and TelemedicinePhysicians and caregivers can remotely monitor patient treatment adherence via cloud data and provide timely intervention. Combined with data from other wearable devices, comprehensive health management is enabled.

V. Revolutionary Breakthroughs in Materials and Structures

Bioresorbable NeedlesFabricated from materials such as polylactic acid, these needles safely degrade in the body after completing drug delivery or monitoring tasks without requiring removal, suitable for long‑term implantable sustained‑release drug or monitoring systems.

Bionic‑Structure NeedlesInspired by the mouthparts of mosquitoes or biting organs of parasites, vibratory or asymmetric serrated needle designs achieve penetration with lower force and reduced nerve stimulation.

Conclusion: An Intelligent Life‑Information Interface from Mechanical to Smart

The operational theory of future hypodermic needles will form a complex system integrating micro‑fluid mechanics, microelectronic sensing, biochemistry, wireless communication and artificial intelligence algorithms. No longer passive, single‑use puncture tools, they will become "intelligent life interfaces" capable of sensing the human micro‑environment, interacting with the body, and dynamically adjusting drug delivery strategies based on individual physiological status.

This revolution will redefine injection, the most fundamental medical procedure, transforming it from an intimidating, standardised "treatment" into a highly personalised, precise, humanised and even painless "health management experience". It represents not merely technological evolution, but also a microcosm of the shift in medical philosophy from "disease treatment" to "health enhancement".